Novo Nordisks Wegovy cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease

10 months ago

Compared with tirzepatide, Wegovy® (semaglutide 2.4 mg) showed a significant 57% greater reduction in the risk of heart attack, stroke…

KFSHRC Strengthens Its Position as a Fast-Growing Destination for International Patients

10 months ago

RIYADH, Saudi Arabia, Aug. 30, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC), ranked 15th globally…

FY Energy Launches BTC Cloud Computing Contracts Backed by Green Energy as Institutional Demand Surges

10 months ago

New Jersey City, Aug. 30, 2025 (GLOBE NEWSWIRE) -- Amid growing institutional participation and regulatory milestones in the cryptocurrency sector,…

FYEnergy Ramps Up ETH Staking Offers as Ethereum Powers U.S. Blockchain Push & DeFi Soars

10 months ago

New York City, NY, Aug. 30, 2025 (GLOBE NEWSWIRE) -- In response to Ethereum’s historic performance this month, FY Energy is…

Trade Vector AI: How Trade Vector Artificial Intelligence Platform Is Transforming Automated Trading Systems

10 months ago

New York City, NY, Aug. 30, 2025 (GLOBE NEWSWIRE) -- Introduction – What is Trade Vector AI Trade Vector AI…

Mind Over Mont Blanc: ASICS Athlete Tom Evans Wins UTMB 2025, Teammate Ben Dhiman Takes Second

10 months ago

The ASICS Trail Team is taking body and mind to new heights during this year’s UTMB® races, including the incredible…

Bybit x Santiment DeFi Report: Platform Tokens Shine As MNT Sees Over $1M Whale Transactions

10 months ago

DUBAI, UAE, Aug. 30, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has released a DeFi report in…

Wonderful Indonesia Shines at ITB India 2025: From Bali to Beyond

10 months ago

MUMBAI, India , Aug. 30, 2025 /PRNewswire/ -- Indonesia is set to make a strong statement at ITB India 2025, bringing the…

Novartis Leqvio shows statistically significant and clinically meaningful early LDL-C goal achievement with less muscle pain

10 months ago

V-DIFFERENCE is first study to show that Leqvio prioritized after statins helps more patients achieve guideline low-density lipoprotein cholesterol (LDL-C)…

Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension

10 months ago

Phase III trial informed by comprehensive KARDIA data set generated through three Phase II studies: KARDIA-1, KARDIA-2 and KARDIA-3In the…